Atrion Corporation – NASDAQ:ATRI

Financial Health
0
1
2
3
4
5
6
7
8
9

Atrion stock price monthly change

+0.52%
month

Atrion stock price quarterly change

+8.57%
quarter

Atrion stock price yearly change

-20.47%
year

Atrion key metrics

Market Cap
809.43M
Enterprise value
797.97M
P/E
64.49
EV/Sales
4.39
EV/EBITDA
26.95
Price/Sales
4.45
Price/Book
3.39
PEG ratio
100.36
EPS
10.64
Revenue
176.66M
EBITDA
29.67M
Income
18.71M
Revenue Q/Q
18.35%
Revenue Y/Y
0.17%
Profit margin
6.91%
Oper. margin
7.93%
Gross margin
32.08%
EBIT margin
7.93%
EBITDA margin
16.8%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Atrion stock price history

Atrion stock forecast

Atrion financial statements

Atrion Corporation (NASDAQ:ATRI): Profit margin
Jun 2023 43.83M 6.56M 14.97%
Sep 2023 41.91M 2.93M 7.01%
Dec 2023 43.58M 6.42M 14.74%
Mar 2024 47.33M 2.79M 5.9%
0.95%
Yield TTM
Atrion Corporation (NASDAQ:ATRI): Payout ratio
Payout ratio 123.33%
Atrion Corporation (NASDAQ:ATRI): Dividend Yield
2019 0.77%
2020 1.03%
2021 1.05%
2022 1.46%
2023 2.3%
Atrion Corporation (NASDAQ:ATRI): Debt to assets
Jun 2023 266825000 25.90M 9.71%
Sep 2023 264809000 24.62M 9.3%
Dec 2023 260825000 17.93M 6.88%
Mar 2024 258627000 16.70M 6.46%
Atrion Corporation (NASDAQ:ATRI): Cash Flow
Jun 2023 -598K -2.63M -1.02M
Sep 2023 5.41M -1.84M -3.22M
Dec 2023 10.85M 420K -8.37M
Mar 2024 11.49M -4.03M -3.89M

Atrion alternative data

Atrion Corporation (NASDAQ:ATRI): Employee count
Aug 2023 722
Sep 2023 722
Oct 2023 722
Nov 2023 722
Dec 2023 722
Jan 2024 722
Feb 2024 722
Apr 2024 712
May 2024 712
Jun 2024 712
Jul 2024 712

Atrion other data

32.81% -30.64%
of ATRI is owned by hedge funds
587.24K -547.17K
shares is hold by hedge funds

Atrion Corporation (NASDAQ:ATRI): Insider trades (number of shares)
Period Buy Sel
Aug 2023 200 0
Nov 2023 300 0
Dec 2023 300 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
BATTAT DAVID A officer: Presiden.. common stock 310 N/A N/A
Option
BATTAT EMILE A director common stock 310 N/A N/A
Option
BATTAT EMILE A director restricted stock units 310 N/A N/A
Option
BATTAT DAVID A officer: Presiden.. common stock 310 N/A N/A
Option
BATTAT DAVID A officer: Presiden.. restricted stock units 310 N/A N/A
Option
FERGUSON CINDY officer: Officer / CFO
restricted stock units 163 N/A N/A
Option
FERGUSON CINDY officer: Officer / CFO
common stock 163 N/A N/A
Purchase
ATHEY PRESTON G director
common stock 300 $319.68 $95,904
Purchase
BATTAT DAVID A officer: Presiden.. common stock 300 $300 $90,000
Purchase
ATHEY PRESTON G director
common stock 200 $523.35 $104,670
Wednesday, 14 August 2024
investorplace.com
Friday, 9 August 2024
zacks.com
Thursday, 8 August 2024
globenewswire.com
Monday, 29 July 2024
prnewswire.com
Sunday, 28 July 2024
accesswire.com
Wednesday, 17 July 2024
globenewswire.com
Tuesday, 16 July 2024
globenewswire.com
Monday, 15 July 2024
prnewswire.com
Monday, 8 July 2024
globenewswire.com
Wednesday, 3 July 2024
prnewswire.com
Friday, 7 June 2024
zacks.com
Tuesday, 28 May 2024
prnewswire.com
prnewswire.com
businesswire.com
globenewswire.com
businesswire.com
Tuesday, 21 May 2024
globenewswire.com
Friday, 10 May 2024
globenewswire.com
Thursday, 29 February 2024
globenewswire.com
Tuesday, 27 February 2024
globenewswire.com
Thursday, 16 November 2023
Seeking Alpha
Friday, 8 September 2023
Seeking Alpha
Tuesday, 8 August 2023
GuruFocus
Monday, 26 June 2023
Seeking Alpha
Sunday, 25 June 2023
Seeking Alpha
Saturday, 25 March 2023
Seeking Alpha
Saturday, 11 March 2023
Seeking Alpha
Thursday, 8 December 2022
Seeking Alpha
Thursday, 8 September 2022
Seeking Alpha
Wednesday, 29 December 2021
Seeking Alpha
  • When is Atrion's next earnings date?

    Unfortunately, Atrion's (ATRI) next earnings date is currently unknown.

  • Does Atrion pay dividends?

    Yes, Atrion pays dividends and its trailing 12-month yield is 0.96% with 123% payout ratio.It means that the company is paying a dividend greater than earnings. The last Atrion stock dividend of $1.95 was paid on 15 Dec 2021.

  • How much money does Atrion make?

    Atrion has a market capitalization of 809.43M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 7.73% to 169.33M US dollars.

  • What is Atrion's stock symbol?

    Atrion Corporation is traded on the NASDAQ under the ticker symbol "ATRI".

  • What is Atrion's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of Atrion?

    Shares of Atrion can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Atrion's key executives?

    Atrion's management team includes the following people:

    • Mr. David A. Battat Pres & Chief Executive Officer(age: 55, pay: $1,070,000)
    • Mr. Jeffery Strickland Chief Financial Officer, Vice President, Treasurer & Sec.(age: 66, pay: $655,660)
    • Mr. Emile A. Battat Executive Chairman(age: 87, pay: $618,090)
  • How many employees does Atrion have?

    As Jul 2024, Atrion employs 712 workers.

  • When Atrion went public?

    Atrion Corporation is publicly traded company for more then 45 years since IPO on 18 Mar 1980.

  • What is Atrion's official website?

    The official website for Atrion is atrioncorp.com.

  • Where are Atrion's headquarters?

    Atrion is headquartered at One Allentown Parkway, Allen, TX.

  • How can i contact Atrion?

    Atrion's mailing address is One Allentown Parkway, Allen, TX and company can be reached via phone at +972 3909800.

Atrion company profile:

Atrion Corporation

atrioncorp.com
Exchange:

NASDAQ

Full time employees:

712

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

One Allentown Parkway
Allen, TX 75002-4211

CIK: 0000701288
ISIN: US0499041053
CUSIP: 049904105